NCT00003499View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

March 6, 1996

Primary Completion Date

September 13, 2003

Study Completion Date

September 13, 2003

Conditions
Low-Grade Lymphoma
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

"Patients with Low-grade non-Hodgkin's lymphoma will receive Antineoplaston therapy (Atengenal + Astugenal).~The daily doses of A10 and AS2-1 are divided into six infusions, which are given at 4-hourly intervals. Each infusion starts with infusion of A10 and is immediately followed by infusion of AS2-1."

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER